Key Highlights

  • Revenue for the six months to 30 June 2026 rose about 33% to roughly GBP 42.4 million, driven largely by acquisitions.
  • The group acquired SSE plc's National Compliance and Testing division and sold Premier Limpet for around GBP 10.1 million.
  • Net Debt fell to GBP 2.9 million from GBP 11 million, with cash rising to GBP 13.8 million.
  • Adjusted EBITDA growth of 9% against 33% Revenue growth points to some Margin dilution from newly acquired businesses.

Amcomri Group (LSE:AMCO) is exactly the sort of company that rarely troubles the headlines but can quietly compound: a small-cap buy, improve, build industrial group assembling niche engineering and Manufacturing businesses. With the shares catching a bid and a busy first half of corporate activity behind it, Amcomri is emerging as one of AIM's more active under-the-radar consolidators. The model is a familiar one on AIM, but its success rests entirely on execution - on buying well and improving what it buys - which is where the scrutiny falls.

Business model

The group follows a disciplined acquire-and-improve strategy, buying established but often underperforming industrial businesses, professionalising them and building scale. It now comprises around 15 operating companies across two divisions: Embedded Engineering, which provides technical services to infrastructure and mass-transportation clients, and B2B Manufacturing, focused on defensible niche products. The appeal of the model is Diversification of customers and end-markets, combined with the potential for margin uplift as acquired firms are integrated. Buying at modest multiples and improving operations is intended to create value both through Earnings growth and, over time, a re-rating of the enlarged group. The two-division structure is intended to give the group some balance between steadier service revenue and product manufacturing.

Latest developments

The trading update for the six months to 30 June 2026 pointed to strong momentum. Revenue rose about 33% to roughly GBP 42.4 million, driven largely by acquisitions, while adjusted EBITDA increased 9% to GBP 4.7 million. Reported profit after tax jumped to GBP 7.3 million from GBP 1.5 million, though that figure was flattered by corporate activity rather than pure trading. The half was notably transactional: Amcomri acquired SSE plc's National Compliance and Testing division through its GridCore Electrical Services subsidiary; sold Premier Limpet for around GBP 10.1 million, realising roughly GBP 7 million of net cash; and, just after the period end, bought North West Transport Supplies in July. Full interim results are due on 15 September 2026.

Balance sheet

The Balance Sheet strengthened materially. Net debt fell to GBP 2.9 million from GBP 11 million, and cash rose to GBP 13.8 million, helped by the Premier Limpet disposal proceeds. That improved firepower matters for a buy-and-build story, because acquisitions must be funded without over-stretching the balance sheet or leaning too heavily on dilutive equity. The combination of falling Leverage and rising cash gives Amcomri room to pursue further deals from a position of relative strength, and the willingness to sell as well as buy suggests a degree of portfolio discipline. A low-leverage, cash-backed position is precisely the footing from which a serial acquirer prefers to operate.

Risks

The risks are those inherent in acquisitive small-caps. Buy-and-build models depend on management's ability to integrate businesses and deliver the promised operational improvements; a stumble on integration, or overpaying for an acquisition, can quickly unwind the thesis. The 9% EBITDA growth against 33% revenue growth hints at margin dilution from newly acquired, lower-margin businesses - a dynamic worth monitoring. Other risks include customer concentration within individual operating companies, cyclicality in industrial end-markets, funding needs for future deals, and the thin Liquidity typical of AIM micro-caps. The headline profit boost from disposals also means investors should focus on underlying, organic trends rather than reported figures.

Outlook

The wider context is an appetite among investors for cash-generative, dividend-capable small industrials that can grow through consolidation while much of the UK market remains subdued. Potential catalysts include the 15 September interim results, evidence of organic growth alongside acquisitions, and further earnings-accretive deals funded from the strengthened balance sheet.

The key question is whether Amcomri can keep sourcing sensibly-priced businesses and convert them into sustained margin and cash-flow gains. Investors may watch the quality of that organic progress closely as the group scales.